Table 1 Patient characteristics
From: Single-center evaluation of prognostic factors for thymoma treated by surgery: a retrospective study
Characteristics | |
|---|---|
Age (years) | |
Mean ± SD | 61 ± 14.9 |
Range | 25–83 |
Sex, n(%) | |
Male | 30(50) |
Female | 30(50) |
Masaoka stage, n (%) | |
I | 47(78) |
II | 4(7) |
III | 3(5) |
IVa | 4(7) |
IVb | 2(3) |
TNM stage, n(%) | |
I | 51(85) |
II | 1(2) |
IIIa | 2(3) |
IIIb | 0(0) |
IVa | 5(8) |
IVb | 1(2) |
Thymoma-related syndrome, n(% | |
Myasthenia gravis | 11(18) |
Pure Red Cell Aplasia | 1(2) |
Lichen planus | 1(2) |
Histological type, n(%) | |
A | 6(10) |
AB | 14(23) |
B1 | 11(18) |
B2 | 22(37) |
B3 | 7(12) |
Tumor size (cm) | |
Mean ± SD | 5.4 ± 2.2 |
Range | 1.1–10 |
Operative approach, n(%) | |
Median sternotomy | 39(65) |
Lateral incision | 1(2) |
Clamshell incision | 5(8) |
Video assisted thoracoscopic surgery | 15(25) |
Operative procedure, n(%) | |
Extended thymectomy | 17(28) |
Thymomectomy | 43(72) |
Operative time (min) | |
Mean ± SD | 184 ± 79 |
Range | 40–362 |
Blood loss (g) | |
Mean ± SD | 94 ± 78 |
Range | 1–360 |
Postoperative treatment, n(%) | |
Radiotherapy | 12(20) |
Chemotherapy | 4(7) |
Resection status, n(%) | |
Complete resection | 53(88) |
Incomplete resection | 7(12) |
Initial relapse site (cases) | |
Pleural dissemination | 6 |
Pulmonary metastasis | 1 |
Local | 1 |
Treatment for recurrence (cases)(overlap) | |
Surgery | 1 |
Chemotherapy | |
protocol | |
ADOC | 2 |
CBDCA+PTX | 1 |
Cisplatin + Etoposide | 1 |
Radiation | 4 |